Cancer treatments led new FDA drug approvals from 2015 to 2020

Cancer treatments led new FDA drug approvals from 2015 to 2020
Image: Intellect (generated)

In short: A review of 245 drugs approved by the U.S. FDA between 2015 and June 2020 found that nearly 29% were approved to treat various types of cancer, making it the single largest therapeutic category, ahead of infectious diseases, neurological conditions, and other disorders.

The researchers compiled and categorized every drug the FDA approved over this five-year span, including both small-molecule and macromolecule therapies, then broke the list down by condition. Cardiovascular, genetic, and metabolic disorders each accounted for 7-8% of approvals, while 14% targeted infectious disease and 12% targeted neurological conditions.

This is a descriptive tally of approvals rather than a clinical study, so it shows what kinds of drugs reached the market but not how well any of them worked.

Why it matters: Cancer treatments were the single biggest category among new FDA-approved drugs in this period.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/technology-research-analysis-of-fda-approved-drugs-reveals-cancer-as-a-primary-t.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…